In the last trading session, 2,453,486 shares of the FSD Pharma Inc.(NASDAQ:HUGE) were traded, and its beta was 0. Most recently the company’s share price was $2.26, and it changed around -$0.23 or -0.09% from the last close, which brings the market valuation of the company to $42.78 Million. HUGE currently trades at a discount to its 52-week high of $14, offering almost -519.47% off that amount. The share price’s 52-week low was $1.28, which indicates that the current value has risen by an impressive 43.36% since then. We note from FSD Pharma Inc.’s average daily trading volume that its 10-day average is 2.86 Million shares, with the 3-month average coming to 2.68 Million.
FSD Pharma Inc. stock received a consensus recommendation rating of Buy, based on a mean score of 0. If we narrow it down even further, the data shows that none out of 1 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, no body recommended HUGE as a Hold, whereas 1 deemed it a Buy, and no one rated it as Underweight.
FSD Pharma Inc. (NASDAQ:HUGE): Trading Information
Although HUGE has showed a red trend with a performance of -9.24% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of $2.98- on Tuesday, Feb 16 increased the stock’s daily price by 24.16%. The company’s shares are currently up 0.45% year-to-date, but still down -0.2014 over the last five days. On the other hand, FSD Pharma Inc. (NASDAQ:HUGE) is -0.01% down in the 30-day period. We can see from the shorts that 93.38 Million shares have been sold at a short interest cover period of 34.84 day(s).
The consensus price target as assigned by Wall Street analysts is $10, which translates to bears needing to increase their stock price by 342.48% from its current value. Analyst projections state that HUGE is forecast to be at a low of $10 and a high of $10. In order for the stock price to hit the forecast high, the stock would need to surge +342.48% from its current level, while the stock would need to crash 342.48% from its current level to reach the projected low.
FSD Pharma Inc. (HUGE) projections and forecasts
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of 0%. FSD Pharma Inc. earnings are expected to decrease by 0% in 2021, but the outlook is negative 0% per year for the next five years.
FSD Pharma Inc. (NASDAQ:HUGE)’s Biggest Investors
Upon looking at major shareholders, it appears that insiders hold 12.7% of FSD Pharma Inc. shares, and 0.73% of them are in the hands of institutional investors. The stock currently has a share float of 0.83%. FSD Pharma Inc. stock is held by 16 institutions, with Wedbush Securities Inc being the largest institutional investor. By Sep 29, 2020, it held 0.44% of the shares, which is about 64.3 Thousand shares worth $163.97 Thousand.
Renaissance Technologies, LLC, with 0.31% or 46.17 Thousand shares worth $72.02 Thousand as of Dec 30, 2020, holds the second largest percentage of outstanding shares.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.